lasofoxifene has been researched along with methylnitrosourea in 1 studies
| Studies (lasofoxifene) | Trials (lasofoxifene) | Recent Studies (post-2010) (lasofoxifene) | Studies (methylnitrosourea) | Trials (methylnitrosourea) | Recent Studies (post-2010) (methylnitrosourea) |
|---|---|---|---|---|---|
| 88 | 14 | 24 | 3,242 | 10 | 346 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliaga, C; Cohen, LA; Moyer, JD; Pittman, B; Wang, CX; Yu, L | 1 |
1 other study(ies) available for lasofoxifene and methylnitrosourea
| Article | Year |
|---|---|
LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carcinogens; Estrogen Antagonists; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Weight Gain | 2001 |